Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2018-07
-
BCECF-AM for Intracellular pH Measurement: Protocols & Innov
2026-05-14
BCECF-AM stands out as a ratiometric fluorescent probe for live-cell intracellular pH measurement across plant, mammalian, and microbial systems. This article distills best practices from benchmark protocols, highlights comparative advantages for plant protein secretion studies, and delivers troubleshooting expertise to maximize reproducibility and signal fidelity.
-
Transmission Dynamics of Carbapenemase Genes in CREC: Insigh
2026-05-14
This study systematically characterizes carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) from eight teaching hospitals in Guangdong, China. It reveals the high prevalence, transmission potential, and resistance patterns of key CEGs—especially blaNDM-1—offering critical context for ongoing resistance surveillance and antibacterial agent evaluation.
-
Nigericin Sodium Salt: Protocols for Ion Transport Studies
2026-05-13
Nigericin sodium salt is a potassium ionophore that enables precise modulation of ion transport across biological membranes, with applications in cytoplasmic pH regulation, platelet aggregation studies, and selective Pb2+ ion transport. It is not suitable for diagnostic or medical use and should be handled under stringent laboratory protocols for scientific research only.
-
Nystatin (Fungicidin): Reliable Antifungal Solutions for Res
2026-05-13
This article explores laboratory scenarios where Nystatin (Fungicidin) (SKU B1993) delivers reproducible, data-driven solutions to common assay challenges. It highlights validated use cases and protocol guidance for biomedical researchers, emphasizing the product’s compatibility, rigor, and evidence-backed performance.
-
hiPSC-Derived Intestinal Organoids Enable Human Pharmacokine
2026-05-12
This study establishes a streamlined protocol for generating human induced pluripotent stem cell-derived intestinal organoids (hiPSC-IOs) with high proliferative and differentiation capacity. The resulting organoids provide a more physiologically relevant in vitro model for pharmacokinetic and drug metabolism research, overcoming limitations of animal models and conventional cell lines.
-
Lipid Nanoparticle Structure and Administration Shape mRNA D
2026-05-12
Chaudhary et al. provide key insights into how the structure of lipid nanoparticles (LNPs) and the route of administration influence the potency, immunogenicity, and maternal-fetal safety of mRNA therapies during pregnancy. Their work delivers mechanistic guidance for designing LNP-mRNA systems, addressing a critical gap in safe RNA-based interventions for pregnancy-related disorders.
-
O-GlcNAcylation Regulates Ferroptosis and Trophoblast Syncyt
2026-05-11
This study uncovers how O-GlcNAc modification of HUWE1 orchestrates the ubiquitination of transferrin receptor 1 (TfR1), regulating iron uptake, ferroptosis, and syncytialization in placental trophoblasts during preeclampsia. The findings establish O-GlcNAcylation as a pivotal modulator of placental pathology and suggest new mechanistic targets for mitigating adverse pregnancy outcomes.
-
EPZ-6438 (SKU A8221): Precision EZH2 Inhibition in Epigeneti
2026-05-11
This article explores real-world laboratory scenarios where EPZ-6438 (SKU A8221) addresses challenges in cell viability, proliferation, and cytotoxicity assays. By integrating evidence-based Q&A, it demonstrates how this highly selective EZH2 inhibitor supports reproducible, data-driven workflows for biomedical researchers.
-
Deferasirox: Oral Iron Chelator for Targeted Iron Metabolism
2026-05-10
Deferasirox is redefining research on iron overload and cancer by enabling precise control of cellular iron pools and metabolic stress responses. This article delivers a protocol-centric guide to experimental workflows, troubleshooting, and advanced applications—bridging recent insights into nutrient sensing and ferroptosis resistance.
-
Cholesterol Impairs Lipid Nanoparticle Trafficking in Cells
2026-05-09
This study reveals that elevated cholesterol levels in lipid nanoparticles (LNPs) hinder their intracellular trafficking and cargo delivery by promoting aggregation in early endosomes. The research leverages a highly sensitive streptavidin–biotin-DNA tracking platform, offering mechanistic insight for optimizing LNP formulations in nucleic acid delivery applications.
-
Meropenem Trihydrate in Resistance Phenotyping Workflows
2026-05-08
Meropenem trihydrate unlocks advanced, reproducible workflows for antibiotic resistance studies and robust infection modeling. Explore stepwise protocols, troubleshooting strategies, and the transformative impact of metabolomics-based resistance detection, all leveraging APExBIO’s rigorously validated carbapenem antibiotic.
-
LY294002: Translational Leverage in PI3K Pathway and Beyond
2026-05-08
This article provides translational researchers with a mechanistic, evidence-driven framework for deploying LY294002—a potent, reversible class I PI3K inhibitor—in the interrogation of PI3K/Akt/mTOR signaling, autophagy, and apoptosis. Drawing from recent neuroinflammation and oncology studies, we discuss protocol optimization, emerging cross-domain applications, and next-generation experimental strategies. The narrative integrates primary literature, product intelligence, and competitive context, demonstrating how APExBIO’s LY294002 advances research beyond conventional use cases.
-
A 83-01 (ALK-5 Inhibitor): Precision Control in Human Organo
2026-05-07
Explore how A 83-01, a selective ALK-5 inhibitor, enables refined modulation of TGF-β signaling for balancing self-renewal and differentiation in advanced human organoid research. Discover new assay strategies grounded in recent breakthroughs.
-
Meropenem: A Carbapenem Benchmark for Resistance Modeling &
2026-05-07
Explore Meropenem, an ultra-broad-spectrum β-lactam antibiotic carbapenem, as a precision tool for dissecting resistance in Gram-negative and Gram-positive bacteria. This article uniquely focuses on translational assay design, protocol optimization, and practical insights for research models.
-
Predicting Compound Mechanism Across Cell Lines Using ML Cla
2026-05-06
Warchal et al. critically evaluated machine learning classifiers for predicting compound mechanism of action (MoA) using high-content image data across genetically distinct cancer cell lines. Their findings reveal the strengths and limitations of ensemble-based and deep learning approaches, with important implications for phenotypic drug screening and translational cancer research.